0JW9 Stock Chart & Stats
$1.02
-$0.02(-1.98%)
At close: 4:00 PM EDT
$1.02
-$0.02(-1.98%)
Day’s Range― - ―
52-Week Range$0.70 - $2.40
Previous CloseN/A
Volume293.00
Average Volume (3M)10.62K
Market Cap
$37.10M
Enterprise Value$33.88M
Total Cash (Recent Filing)$5.71M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.95
Next Earnings
Nov 05, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield28.83%
Share Statistics
EPS (TTM)-9.11
Shares Outstanding30,407,269
10 Day Avg. Volume7,027
30 Day Avg. Volume10,621
Financial Highlights & Ratios
PEG Ratio0.03
Price to Book (P/B)0.77
Price to Sales (P/S)0.00
P/FCF Ratio-3.49
Enterprise Value/Market Cap0.91
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-2.78
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-1.56
Revenue Forecast (FY)$25.00M
Bulls Say, Bears Say
Bulls Say
Conservative LeverageZero total debt across 2024–2026 gives Lite Strategy a conservative leverage profile and avoids interest obligations. This flexibility can help preserve capital for treasury, pharmaceutical, or ecosystem initiatives, although it does not by itself establish operating profitability.
Litecoin Treasury StrategyThe Litecoin-focused treasury model creates a defined strategic identity, while covered-call income and an authorized repurchase program add supporting capital-management tools. These initiatives may strengthen asset utilization and shareholder positioning over the next several months.
Asset And Ecosystem DiversificationCombining digital-asset treasury operations with pharmaceutical assets and a Litecoin-based Layer 2 investment gives Lite Strategy multiple potential sources of strategic value. Milestone payments, out-licensing, and ecosystem development could broaden the business beyond a single asset exposure.
Bears Say
No Current RevenueRevenue falling to zero for two consecutive annual periods indicates that the company currently lacks a dependable operating revenue base. Without recurring sales, strategic initiatives remain difficult to evaluate through business performance, and future earnings depend on restoring commercial activity.
Volatile And Worsening ProfitabilityThe sharp reversal from 2024 profitability to sizable losses in 2025 and an even larger loss in 2026 shows that earnings are not yet repeatable. Sustained losses can consume equity, weaken financial resilience, and make long-term business performance heavily dependent on future strategic execution.
Persistent Cash BurnPersistent negative operating and free cash flow means Lite Strategy is consuming rather than generating cash, despite some improvement in 2025 and 2026. Continued burn can increase reliance on external funding and constrain the company’s ability to finance growth without dilution or capital actions.
Lite Strategy News
0JW9 FAQ
What was Lite Strategy’s price range in the past 12 months?
Lite Strategy lowest share price was $0.70 and its highest was $2.40 in the past 12 months.
What is Lite Strategy’s market cap?
Lite Strategy’s market cap is $37.10M.
When is Lite Strategy’s upcoming earnings report date?
Lite Strategy’s upcoming earnings report date is Nov 05, 2026 which is in 23 days.
How were Lite Strategy’s earnings last quarter?
Lite Strategy released its earnings results on May 13, 2026. The company reported -$0.664 earnings per share for the quarter.
Is Lite Strategy overvalued?
According to Wall Street analysts Lite Strategy’s price is currently Overvalued.
Does Lite Strategy pay dividends?
Lite Strategy pays a Notavailable dividend of $1.75 which represents an annual dividend yield of 28.83%. See more information on Lite Strategy dividends here
What is Lite Strategy’s EPS estimate?
Lite Strategy’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Lite Strategy have?
Lite Strategy has 30,407,269 shares outstanding.
What happened to Lite Strategy’s price movement after its last earnings report?
Lite Strategy reported an EPS of -$0.664 in its last earnings report. Following the earnings report the stock price went up 2.542%.
Which hedge fund is a major shareholder of Lite Strategy?
Currently, no hedge funds are holding shares in GB:0JW9
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Lite Strategy Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-50.60%
12-Months-Change
Fundamentals
Return on Equity
-97.27%
Trailing 12-Months
Asset Growth
133.48%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Lite Strategy
Lite Strategy, Inc. functions as a clinical-stage pharmaceutical firm, concentrating its efforts on creating innovative and distinct therapeutic solutions for cancer patients. This entity, which was previously known as MEI Pharma, Inc., officially changed its designation to Lite Strategy, Inc. in September 2025. The company was established in 2000 and has its principal operations located in San Diego, California.
Technical Analysis
ABVC BioPharma
―
Jasper Therapeutics
―
Prelude Therapeutics
―
Gain Therapeutics
―
Estrella Immunopharma
―